Combination of Diffusion-weighted Magnetic Resonance Imaging and Extended Prostate Biopsy Predicts Lobes Without Significant Cancer: Application in Patient Selection for Hemiablative Focal Therapy

Ahmed, 2007, Will focal therapy become a standard of care for men with localized prostate cancer?, Nat Clin Pract Oncol, 4, 632, 10.1038/ncponc0959 Eggener, 2010, Focal therapy for prostate cancer: possibilities and limitations, Eur Urol, 58, 57, 10.1016/j.eururo.2010.03.034 Tareen, 2009, Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort, Urology, 73, 351, 10.1016/j.urology.2008.08.504 Wise, 2002, Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens, Urology, 60, 264, 10.1016/S0090-4295(02)01728-4 Noguchi, 2003, Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers, J Urol, 170, 459, 10.1097/01.ju.0000070928.49986.04 Karavitakis, 2011, Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy, Prostate Cancer Prostatic Dis, 14, 46, 10.1038/pcan.2010.16 Bott, 2010, The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer, BJU Int, 106, 1607, 10.1111/j.1464-410X.2010.09436.x Turkbey, 2009, Imaging techniques for prostate cancer: implications for focal therapy, Nat Rev Urol, 6, 191, 10.1038/nrurol.2009.27 Giannarini, 2012, Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature, Eur Urol, 61, 326, 10.1016/j.eururo.2011.09.019 Woodfield, 2010, Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy, Am J Roentgenol, 194, W316, 10.2214/AJR.09.2651 Kawakami, 2006, Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer, Int J Clin Oncol, 11, 127, 10.1007/s10147-005-0547-0 Kawakami, 2008, Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy, Eur Urol, 54, 601, 10.1016/j.eururo.2008.01.017 Li, 2006, Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone, Am J Roentgenol, 186, 729, 10.2214/AJR.04.0775 Epstein, 2005, The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1 Srigley, 2006, Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland, Arch Pathol Lab Med, 130, 936, 10.5858/2006-130-936-UPFTEO Tsivian, 2010, Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended, BJU Int, 105, 1089, 10.1111/j.1464-410X.2009.08904.x Polascik, 2009, Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy, Cancer, 115, 2104, 10.1002/cncr.24258 Eichler, 2006, Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review, J Urol, 175, 1605, 10.1016/S0022-5347(05)00957-2 Tareen, 2009, Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?, BJU Int, 104, 195, 10.1111/j.1464-410X.2009.08347.x Gallina, 2012, Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy, BJU Int, 110, E64, 10.1111/j.1464-410X.2011.10762.x Koh, 2007, Diffusion-weighted MRI in the body: applications and challenges in oncology, Am J Roentgenol, 188, 1622, 10.2214/AJR.06.1403 Giles, 2011, Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components, Am J Roentgenol, 196, 586, 10.2214/AJR.10.5016 Ikonen, 1998, Magnetic resonance imaging of clinically localized prostatic cancer, J Urol, 159, 915, 10.1016/S0022-5347(01)63770-4 Oto, 2011, Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis, Am J Roentgenol, 197, 1382, 10.2214/AJR.11.6861 Numao, 2012, Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy, BJU Int, 109, 665, 10.1111/j.1464-410X.2011.10427.x Moussa, 2010, Importance of additional “extreme” anterior apical needle biopsies in the initial detection of prostate cancer, Urology, 75, 1034, 10.1016/j.urology.2009.11.008 Ahmed, 2011, Characterizing clinically significant prostate cancer using template prostate mapping biopsy, J Urol, 186, 458, 10.1016/j.juro.2011.03.147 Epstein, 2010, An update of the Gleason grading system, J Urol, 183, 433, 10.1016/j.juro.2009.10.046 Ploussard, 2011, The contemporary concept of significant versus insignificant prostate cancer, Eur Urol, 60, 291, 10.1016/j.eururo.2011.05.006 Helpap, 2006, The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens, Virchows Arch, 449, 622, 10.1007/s00428-006-0310-6